Cargando…

Response of Fibroblasts MRC-5 to Flufenamic Acid-Grafted MCM-41 Nanoparticles

Recently, flufenamic acid (FFA) was discovered among fenamates as a free radical scavenger and gap junction blocker; however, its effects have only been studied in cancer cells. Normal cells in the surroundings of a tumor also respond to radiation, although they are not hit by it directly. This phen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara, Giovanna Gomes, Cipreste, Marcelo Fernandes, Andrade, Gracielle Ferreira, da Silva, Wellington Marcos, de Sousa, Edésia Martins Barros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874870/
https://www.ncbi.nlm.nih.gov/pubmed/29315235
http://dx.doi.org/10.3390/bioengineering5010004
_version_ 1783310249533374464
author Lara, Giovanna Gomes
Cipreste, Marcelo Fernandes
Andrade, Gracielle Ferreira
da Silva, Wellington Marcos
de Sousa, Edésia Martins Barros
author_facet Lara, Giovanna Gomes
Cipreste, Marcelo Fernandes
Andrade, Gracielle Ferreira
da Silva, Wellington Marcos
de Sousa, Edésia Martins Barros
author_sort Lara, Giovanna Gomes
collection PubMed
description Recently, flufenamic acid (FFA) was discovered among fenamates as a free radical scavenger and gap junction blocker; however, its effects have only been studied in cancer cells. Normal cells in the surroundings of a tumor also respond to radiation, although they are not hit by it directly. This phenomenon is known as the bystander effect, where response molecules pass from tumor cells to normal ones, through communication channels called gap junctions. The use of the enhanced permeability and retention effect, through which drug-loaded nanoparticles smaller than 200 nm may accumulate around a tumor, can prevent the local side effect upon controlled release of the drug. The present work, aimed at functionalizing MCM-41 (Mobil Composition of Matter No. 41) silica nanoparticles with FFA and determining its biocompatibility with human fibroblasts MRC-5 (Medical Research Council cell strain 5). MCM-41, was synthesized and characterized structurally and chemically, with multiple techniques. The biocompatibility assay was performed by Live/Dead technique, with calcein and propidium–iodide. MRC-5 cells were treated with FFA-grafted MCM-41 for 48 h, and 98% of cells remained viable, without signs of necrosis or morphological changes. The results show the feasibility of MCM-41 functionalization with FFA, and its potential protection of normal cells, in comparison to the role of FFA in cancerous ones.
format Online
Article
Text
id pubmed-5874870
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58748702018-04-02 Response of Fibroblasts MRC-5 to Flufenamic Acid-Grafted MCM-41 Nanoparticles Lara, Giovanna Gomes Cipreste, Marcelo Fernandes Andrade, Gracielle Ferreira da Silva, Wellington Marcos de Sousa, Edésia Martins Barros Bioengineering (Basel) Article Recently, flufenamic acid (FFA) was discovered among fenamates as a free radical scavenger and gap junction blocker; however, its effects have only been studied in cancer cells. Normal cells in the surroundings of a tumor also respond to radiation, although they are not hit by it directly. This phenomenon is known as the bystander effect, where response molecules pass from tumor cells to normal ones, through communication channels called gap junctions. The use of the enhanced permeability and retention effect, through which drug-loaded nanoparticles smaller than 200 nm may accumulate around a tumor, can prevent the local side effect upon controlled release of the drug. The present work, aimed at functionalizing MCM-41 (Mobil Composition of Matter No. 41) silica nanoparticles with FFA and determining its biocompatibility with human fibroblasts MRC-5 (Medical Research Council cell strain 5). MCM-41, was synthesized and characterized structurally and chemically, with multiple techniques. The biocompatibility assay was performed by Live/Dead technique, with calcein and propidium–iodide. MRC-5 cells were treated with FFA-grafted MCM-41 for 48 h, and 98% of cells remained viable, without signs of necrosis or morphological changes. The results show the feasibility of MCM-41 functionalization with FFA, and its potential protection of normal cells, in comparison to the role of FFA in cancerous ones. MDPI 2018-01-09 /pmc/articles/PMC5874870/ /pubmed/29315235 http://dx.doi.org/10.3390/bioengineering5010004 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lara, Giovanna Gomes
Cipreste, Marcelo Fernandes
Andrade, Gracielle Ferreira
da Silva, Wellington Marcos
de Sousa, Edésia Martins Barros
Response of Fibroblasts MRC-5 to Flufenamic Acid-Grafted MCM-41 Nanoparticles
title Response of Fibroblasts MRC-5 to Flufenamic Acid-Grafted MCM-41 Nanoparticles
title_full Response of Fibroblasts MRC-5 to Flufenamic Acid-Grafted MCM-41 Nanoparticles
title_fullStr Response of Fibroblasts MRC-5 to Flufenamic Acid-Grafted MCM-41 Nanoparticles
title_full_unstemmed Response of Fibroblasts MRC-5 to Flufenamic Acid-Grafted MCM-41 Nanoparticles
title_short Response of Fibroblasts MRC-5 to Flufenamic Acid-Grafted MCM-41 Nanoparticles
title_sort response of fibroblasts mrc-5 to flufenamic acid-grafted mcm-41 nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874870/
https://www.ncbi.nlm.nih.gov/pubmed/29315235
http://dx.doi.org/10.3390/bioengineering5010004
work_keys_str_mv AT laragiovannagomes responseoffibroblastsmrc5toflufenamicacidgraftedmcm41nanoparticles
AT ciprestemarcelofernandes responseoffibroblastsmrc5toflufenamicacidgraftedmcm41nanoparticles
AT andradegracielleferreira responseoffibroblastsmrc5toflufenamicacidgraftedmcm41nanoparticles
AT dasilvawellingtonmarcos responseoffibroblastsmrc5toflufenamicacidgraftedmcm41nanoparticles
AT desousaedesiamartinsbarros responseoffibroblastsmrc5toflufenamicacidgraftedmcm41nanoparticles